NCT05435703View on ClinicalTrials.gov

Renal Cysts and Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Primary Aldosteronism
Trial Locations (1)

33521

Tampere University Hospital, Tampere

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

collaborator

Kuopio University Hospital

OTHER

collaborator

Tampere University

OTHER

lead

Tampere University Hospital

OTHER

NCT05435703 - Renal Cysts and Primary Aldosteronism | Biotech Hunter | Biotech Hunter